Gordon Best is a finance journalist who writes for Fool UK and Yahoo Finance UK. With a focus on the stock market and investing, Gordon provides insights and analysis on various companies and their potential for growth. His articles aim to inform readers about potential investment opportunities and offer guidance on navigating the world of finance.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United Kingdom (National)
Gordon Best's articles predominantly focus on investment analysis, often citing data to support his insights. He appears particularly interested in stocks, dividends, and the performance of companies listed on the FTSE index.
Given his focus on investment analysis and reliance on data, Gordon would likely be receptive to pitches offering expert insights into stock performance or market trends supported by credible data. Additionally, he may appreciate access to experts who can provide forward-looking projections based on thorough financial analyses.
As Gordon does not have a specified geographic focus, it is advisable for pitches to offer insights relevant to a global audience or specific sectors that are internationally significant.
This information evolves through artificial intelligence and human feedback. Improve this profile .
With a new government now in place, many investors are getting excited about the housing sector again. So are Persimmon shares the way to go?
By: Gordon Best
The Premier African Minerals (LSE:PREM) share price is down a whopping 85% in the last year, so what happened? Gordon Best takes a look.
Most investors would be cautious after seeing a stock grow by more than 30% in a year, but this FTSE 250 company might just be getting started.
NIO stock has been on a bumpy road for a number of years, but as use of electric vehicles continues to grow, is there a recovery on the cards?
The mining sector has always interested investors. But after a flat few years, I'm wondering what's next for the Anglo American share price.
By: Gordon Best
The AstraZeneca share price has had a great few years, as acquisitions and clinical trials delighted shareholders. So is there more to come?
By: Gordon Best
After touching all-time highs yesterday, the Apple share price is on a roll. But is there still enough growth ahead to start investing now?
Following the release of it's latest production report, the Fresnillo share price is on the move, but what's next for this mining giant?
The Next share price has had an impressive year or so, but I think there could still be more growth ahead. Here's why I'm interested.
The FTSE 100 is full of opportunities for the patient investor, and I think I may have found one that merits a closer look.
(833) 317-6278 
